The successful implementation of fused deposition modeling (FDM) in pharmaceutical manufacturing hinges on overcoming the inherent brittleness and poor extrusion behavior of many polymer-based materials. This study presents a comprehensive investigation into the mechanistic underpinnings of printability enhancement in two model polymers—plasticized Eudragit® EPO and Soluplus®—through strategic additive engineering. Three distinct modification strategies were employed: incorporation of inert fillers (talc), high-melting-point drugs (diclofenac sodium), and high-strength polymers (plasticized ethylcellulose). The interplay between additive concentration, material properties, and printing performance was analyzed using a combination of experimental testing and advanced simulation techniques.
Addition of talc significantly improved the mechanical robustness of both polymers by acting as a reinforcing agent. In Eudragit® EPO, talc concentrations between 37.5% and 50% yielded filaments with optimal strength (3.6–5.7 MPa) and controlled ductility (elongation at break ~69%), enabling stable extrusion without bending or nozzle clogging. For Soluplus®, a lower talc range (25–37.5%) was effective, suggesting greater sensitivity to filler content due to differences in molecular structure and melt rheology. The rigid talc particles restricted polymer chain mobility, increasing resistance to deformation while reducing excessive elongation that leads to stringing.
Diclofenac sodium, with its high melting point (288 °C), functioned as an internal hardener. In Eudragit® EPO, a 40% loading level provided sufficient rigidity for complete printlet formation, whereas higher levels resulted in brittle filaments prone to fracture. In contrast, Soluplus® formulations required only 2.5–7.5% DS to achieve comparable improvements, indicating a stronger interaction between DS and the Soluplus® matrix, possibly through hydrogen bonding. This suggests that drug-polymer interactions can be leveraged not only for formulation stability but also for mechanical reinforcement.
Blending with plasticized ethylcellulose emerged as a particularly effective strategy. At 20–50% concentration, the addition of EC enhanced tensile strength while maintaining acceptable flexibility. The plasticized EC acted as a structural scaffold, improving load-bearing capacity during extrusion and layer deposition.CLEC2 Antibody Autophagy Notably, this approach allowed for fine-tuning of release kinetics, offering dual benefits in mechanical performance and functional design.MBP Antibody Formula
Finite element method (FEM) simulations revealed that printable filaments must withstand radial stress without exceeding yield limits.PMID:35012429 The simulated von Mises stress in optimized formulations remained below the material’s breaking strength, confirming structural integrity during gear-driven extrusion. Computational fluid dynamics (CFD) analysis demonstrated that shear-thinning behavior and moderate melt viscosity (e.g., ~124 Pa·s for Soluplus®-talc) enabled efficient flow through the nozzle, minimizing pressure buildup and preventing blockage.
These findings highlight that printability is governed by a delicate balance between mechanical strength and flexibility, modulated by additive selection and concentration. The integration of simulation tools enables predictive assessment of filament behavior, accelerating formulation development. Ultimately, this work provides a rational framework for transforming inherently non-printable pharmaceutical polymers into viable feedstocks for FDM, paving the way for scalable, personalized drug delivery systems.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
